Literature DB >> 34327664

From Cells to Organs: The Present and Future of Regenerative Medicine.

Yichen Wang1, Yoon-Young Jang2,3.   

Abstract

Regenerative medicine promises a bright future where damaged body parts can be restored, rejuvenated, and replaced. The application of regenerative medicine is interdisciplinary and covers nearly all fields of medical sciences and molecular engineering. This review provides a road map on how regenerative medicine is applied on the levels of cell, tissue, and organ and summarizes the advantages and limitation of human pluripotent stem cells in disease modeling and regenerative application.
© 2021. Springer Nature Switzerland AG.

Entities:  

Keywords:  Cartilage damage; Hepatobiliary disease modeling; Kidney dysfunction; Organoids; Pluripotent stem cells; Regenerative medicine; Sickle cell disease

Mesh：

Year:  2022        PMID： 34327664      PMCID： PMC9301257          DOI： 10.1007/5584_2021_657

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   3.650


  76 in total

1.  De novo mutations in mitochondrial DNA of iPSCs produce immunogenic neoepitopes in mice and humans.

Authors:  Tobias Deuse; Xiaomeng Hu; Sean Agbor-Enoh; Martina Koch; Matthew H Spitzer; Alessia Gravina; Malik Alawi; Argit Marishta; Bjoern Peters; Zeynep Kosaloglu-Yalcin; Yanqin Yang; Raja Rajalingam; Dong Wang; Bjoern Nashan; Rainer Kiefmann; Hermann Reichenspurner; Hannah Valantine; Irving L Weissman; Sonja Schrepfer
Journal:  Nat Biotechnol       Date:  2019-08-19       Impact factor: 54.908

2.  Establishment of hepatic and neural differentiation platforms of Wilson's disease specific induced pluripotent stem cells.

Authors:  Fei Yi; Jing Qu; Mo Li; Keiichiro Suzuki; Na Young Kim; Guang-Hui Liu; Juan Carlos Izpisua Belmonte
Journal:  Protein Cell       Date:  2012-07-18       Impact factor: 14.870

Review 3.  CRISPR/Cas9 for Sickle Cell Disease: Applications, Future Possibilities, and Challenges.

Authors:  Selami Demirci; Alexis Leonard; Juan J Haro-Mora; Naoya Uchida; John F Tisdale
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

Review 4.  Fetal haemoglobin induction in sickle cell disease.

Authors:  Alireza Paikari; Vivien A Sheehan
Journal:  Br J Haematol       Date:  2017-11-16       Impact factor: 6.998

Review 5.  Mesenchymal stem cell-based therapy of osteoarthritis: Current knowledge and future perspectives.

Authors:  C Randall Harrell; Bojana Simovic Markovic; Crissy Fellabaum; Aleksandar Arsenijevic; Vladislav Volarevic
Journal:  Biomed Pharmacother       Date:  2018-11-29       Impact factor: 6.529

6.  Patient-Derived Induced Pluripotent Stem Cells for Alpha-1 Antitrypsin Deficiency Disease Modeling and Therapeutic Discovery.

Authors:  Joseph E Kaserman; Andrew A Wilson
Journal:  Chronic Obstr Pulm Dis       Date:  2018-09-15

7.  Directed differentiation of human induced pluripotent stem cells into functional cholangiocyte-like cells.

Authors:  Miguel Cardoso de Brito; Imbisaat Geti; Alessandro Bertero; Fotios Sampaziotis; Nicholas Rf Hannan; Ludovic Vallier
Journal:  Nat Protoc       Date:  2017-03-23       Impact factor: 13.491

8.  ATP-Binding Cassette Transporter A1 Deficiency in Human Induced Pluripotent Stem Cell-Derived Hepatocytes Abrogates HDL Biogenesis and Enhances Triglyceride Secretion.

Authors:  Xin Bi; Evanthia E Pashos; Marina Cuchel; Nicholas N Lyssenko; Mayda Hernandez; Antonino Picataggi; James McParland; Wenli Yang; Ying Liu; Ruilan Yan; Christopher Yu; Stephanie L DerOhannessian; Michael C Phillips; Edward E Morrisey; Stephen A Duncan; Daniel J Rader
Journal:  EBioMedicine       Date:  2017-03-14       Impact factor: 8.143

9.  Factors affecting mortality during the waiting time for kidney transplantation: A nationwide population-based cohort study using the Korean Network for Organ Sharing (KONOS) database.

Authors:  Sunhwa Lee; Kyung Don Yoo; Jung Nam An; Yun Kyu Oh; Chun Soo Lim; Yon Su Kim; Jung Pyo Lee
Journal:  PLoS One       Date:  2019-04-12       Impact factor: 3.240

Review 10.  iPSC-Derived Hepatocytes as a Platform for Disease Modeling and Drug Discovery.

Authors:  James L Corbett; Stephen A Duncan
Journal:  Front Med (Lausanne)       Date:  2019-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.